Welcome to Iris Biotech
For better service please confirm your country and language we detected.
Währung
EUR
Schneller Kontakt
Bitte senden Sie mir mehr Informationen über
Fmoc-L-Asn(1G,2G,4G)-OH
Chemischer Name: N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N4-((2R,3R,4R,5S,6R)-3-acetamido-5-(((2S,3R,4R,5S,6R)-3-acetamido-5-(((2S,3S,4S,5R,6R)-6-((((2S,3S,4S,5S,6R)-3-(((2S,3R,4R,5S,6R)-3-acetamido-4-hydroxy-6-(hyd roxymethyl)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydr // Synonyme: Fmoc-Asn(1G,2G,4G)-OH, Common glycan name: G3, Oxford glycan name: A3G3, Alternative Glycan name: NA3, GlyCosmos ID: G29857RC
- Art-Nr.:GCN1160
- CAS Nr.:204715-70-8
- Lagertemperatur:-20°C
- Formel:C95H143N7O60
- Molare Masse:2343,18 g/mol
- Reinheit:min.90,0%
Ab 1.280,00 €
description
Fmoc-protected Asn-linked A3G3 glycan for use in solid phase peptide synthesis (SPPS).
references
Prompt Chemoenzymatic Synthesis of Diverse Complex-Type Oligosaccharides and Its Application to the Solid-Phase Synthesis of a Glycopeptide with Asn-Linked Sialyl-undeca- and Asialo-nonasaccharides; Y. Kjihara, Y. Suzuki, N. Yamamoto, K. Sasaki, T. Sakakibara, L. R. Juneja; Chem. Eur. J. 2004; 10: 971-985. https://doi.org/10.1002/chem.200305115
Chemical Synthesis of Homogeneous Human Glycosyl-interferon-â That Exhibits Potent Antitumor Activity in Vivo; I. Sakamoto, K. Tezuka, K. Fukae, K. Ishii, K. Taduru, M. Maeda, M. Ouchi, K. Yoshida, Y. Nambu, J. Igarashi, N. Hayashi, T. Tsuji, Y. Kajihara; J. Am. Chem. Soc. 2012; 134: 5428−5431. https://doi.org/10.1021/ja2109079
Benötigen Sie weitere Informationen über dieses Produkt?
kontaktieren Sie uns
Produkte, die Sie auch interessieren könnten!
